NL1003503C2 - Farmaceutische samenstelling voor orale toediening. - Google Patents

Farmaceutische samenstelling voor orale toediening. Download PDF

Info

Publication number
NL1003503C2
NL1003503C2 NL1003503A NL1003503A NL1003503C2 NL 1003503 C2 NL1003503 C2 NL 1003503C2 NL 1003503 A NL1003503 A NL 1003503A NL 1003503 A NL1003503 A NL 1003503A NL 1003503 C2 NL1003503 C2 NL 1003503C2
Authority
NL
Netherlands
Prior art keywords
composition according
oil
composition
diacerein
surfactant
Prior art date
Application number
NL1003503A
Other languages
English (en)
Dutch (nl)
Inventor
Avraham Cohen
Pierre Metziger
Original Assignee
Negma Steba International Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL1003503A priority Critical patent/NL1003503C2/nl
Application filed by Negma Steba International Dev filed Critical Negma Steba International Dev
Priority to BR9706537-4A priority patent/BR9706537A/pt
Priority to CNB971908419A priority patent/CN1196477C/zh
Priority to PCT/EP1997/003405 priority patent/WO1998001118A1/fr
Priority to ES97928275T priority patent/ES2230608T3/es
Priority to AT97928275T priority patent/ATE275945T1/de
Priority to US09/029,073 priority patent/US5952383A/en
Priority to JP50472298A priority patent/JP4209467B2/ja
Priority to IL12333697A priority patent/IL123336A/xx
Priority to PL97325282A priority patent/PL189358B1/pl
Priority to EP97928275A priority patent/EP0862423B1/fr
Priority to DE69730688T priority patent/DE69730688T2/de
Priority to AU32631/97A priority patent/AU3263197A/en
Priority to CA002231342A priority patent/CA2231342C/fr
Priority to KR1019970033100A priority patent/KR980009519A/ko
Application granted granted Critical
Publication of NL1003503C2 publication Critical patent/NL1003503C2/nl
Priority to MX9801727A priority patent/MX9801727A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
    • B65H23/00—Registering, tensioning, smoothing or guiding webs
    • B65H23/04—Registering, tensioning, smoothing or guiding webs longitudinally
    • B65H23/06—Registering, tensioning, smoothing or guiding webs longitudinally by retarding devices, e.g. acting on web-roll spindle
    • B65H23/10—Registering, tensioning, smoothing or guiding webs longitudinally by retarding devices, e.g. acting on web-roll spindle acting on running web
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/16—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with all layers existing as coherent layers before laminating
    • B32B37/22—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with all layers existing as coherent layers before laminating involving the assembly of both discrete and continuous layers
    • B32B37/223—One or more of the layers being plastic
    • B32B37/226—Laminating sheets, panels or inserts between two continuous plastic layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B38/00—Ancillary operations in connection with laminating processes
    • B32B38/18—Handling of layers or the laminate
    • B32B38/1825—Handling of layers or the laminate characterised by the control or constructional features of devices for tensioning, stretching or registration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2309/00—Parameters for the laminating or treatment process; Apparatus details
    • B32B2309/06—Angles
NL1003503A 1996-07-04 1996-07-04 Farmaceutische samenstelling voor orale toediening. NL1003503C2 (nl)

Priority Applications (16)

Application Number Priority Date Filing Date Title
NL1003503A NL1003503C2 (nl) 1996-07-04 1996-07-04 Farmaceutische samenstelling voor orale toediening.
EP97928275A EP0862423B1 (fr) 1996-07-04 1997-06-30 Composition pharmaceutique pour administration par voie orale
PCT/EP1997/003405 WO1998001118A1 (fr) 1996-07-04 1997-06-30 Composition pharmaceutique pour administration par voie orale
ES97928275T ES2230608T3 (es) 1996-07-04 1997-06-30 Composicion farmaceutica destinada a una administracion por via oral.
AT97928275T ATE275945T1 (de) 1996-07-04 1997-06-30 Oral anzuwendende arzneizubereitung
US09/029,073 US5952383A (en) 1996-07-04 1997-06-30 Pharmaceutical composition for oral delivery
BR9706537-4A BR9706537A (pt) 1996-07-04 1997-06-30 Composição farmacêutica para administração por via oral
IL12333697A IL123336A (en) 1996-07-04 1997-06-30 Pharmaceutical compositions comprising diacerein rhein or a salt thereof for oral administration
PL97325282A PL189358B1 (pl) 1996-07-04 1997-06-30 Kompozycja farmaceutyczna do podawania doustnego
CNB971908419A CN1196477C (zh) 1996-07-04 1997-06-30 用于口服给药的药物组合物
DE69730688T DE69730688T2 (de) 1996-07-04 1997-06-30 Oral anzuwendende arzneizubereitung
AU32631/97A AU3263197A (en) 1996-07-04 1997-06-30 Pharmaceutical composition for oral delivery
CA002231342A CA2231342C (fr) 1996-07-04 1997-06-30 Composition pharmaceutique pour administration par voie orale
JP50472298A JP4209467B2 (ja) 1996-07-04 1997-06-30 経口投与用製剤組成物
KR1019970033100A KR980009519A (ko) 1996-07-04 1997-07-16 롤러들 사이의 핀치안으로 포일스트립을 안내하는 장치
MX9801727A MX9801727A (es) 1996-07-04 1998-03-04 Composicion farmaceutica para administracion oral.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1003503A NL1003503C2 (nl) 1996-07-04 1996-07-04 Farmaceutische samenstelling voor orale toediening.
NL1003503 1996-07-04

Publications (1)

Publication Number Publication Date
NL1003503C2 true NL1003503C2 (nl) 1998-01-07

Family

ID=19763138

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1003503A NL1003503C2 (nl) 1996-07-04 1996-07-04 Farmaceutische samenstelling voor orale toediening.

Country Status (16)

Country Link
US (1) US5952383A (ja)
EP (1) EP0862423B1 (ja)
JP (1) JP4209467B2 (ja)
KR (1) KR980009519A (ja)
CN (1) CN1196477C (ja)
AT (1) ATE275945T1 (ja)
AU (1) AU3263197A (ja)
BR (1) BR9706537A (ja)
CA (1) CA2231342C (ja)
DE (1) DE69730688T2 (ja)
ES (1) ES2230608T3 (ja)
IL (1) IL123336A (ja)
MX (1) MX9801727A (ja)
NL (1) NL1003503C2 (ja)
PL (1) PL189358B1 (ja)
WO (1) WO1998001118A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941966D1 (de) * 1998-02-13 2010-03-11 Nutramax Lab Inc Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CA2533013C (en) * 2003-07-17 2011-07-26 Banner Pharmacaps, Inc. Controlled release preparations
GB0317869D0 (en) * 2003-07-30 2003-09-03 Disperse Ltd Improved drug delivery system
JP5096658B2 (ja) * 2003-10-06 2012-12-12 株式会社三協 生物学的利用能を向上させたソフトカプセル
US7775245B2 (en) 2005-04-08 2010-08-17 Air Products And Chemicals, Inc. Secure loop system and method for supply and delivery of product contained in a carrier
GB0523041D0 (en) * 2005-11-11 2005-12-21 Cyclacel Ltd Combination
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0622479D0 (en) * 2006-11-10 2006-12-20 Sosei R & D Ltd Novel salts and their therapeutic use
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
CN101371823B (zh) * 2007-03-19 2010-09-15 上海慈瑞医药科技有限公司 二乙酰大黄酸缓释胶囊的制备工艺
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US8821924B2 (en) * 2007-09-14 2014-09-02 Wockhardt Ltd. Rhein or diacerein compositions
FR2920991A1 (fr) * 2007-09-14 2009-03-20 Wockhardt Ltd Composition a base de diacerheine pour le traitement de l'arthrose
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
ATE551990T1 (de) * 2007-09-27 2012-04-15 Wockhardt Ltd Selbstemulgierende pharmazeutische zusammensetzungen von rhein oder diacerein
CA2709236A1 (en) 2007-09-27 2009-04-02 Wockhardt Research Centre Pharmaceutical compositions of rhein or diacerein
US20100018107A1 (en) * 2008-07-22 2010-01-28 Christensen Kurt L Method and means for controlling the population of mosquitoes in a non-toxic manner
US9987226B2 (en) * 2010-12-10 2018-06-05 Ns Technologies Pty Ltd Methods for forming miniemulsions and use thereof for delivering bioactive agents
ES2736256T3 (es) 2011-03-14 2019-12-27 Drug Delivery Solutions Ltd Composición oftálmica
EP2793854B1 (en) 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264989A1 (en) * 1986-10-01 1988-04-27 PROTER S.p.A. Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
EP0364944A1 (en) * 1988-10-17 1990-04-25 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
EP0519428A2 (en) * 1991-06-21 1992-12-23 Takeda Chemical Industries, Ltd. Cyclodextrin composition
EP0598337A2 (en) * 1992-11-13 1994-05-25 VECTORPHARMA INTERNATIONAL S.p.A. Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
IT1189097B (it) * 1986-05-02 1988-01-28 Proter Spa Sali di diacetilreina e loro impiego terapeutico nel trattamento dell'artrosi
GB9316923D0 (en) * 1993-08-13 1993-09-29 Lilly Industries Ltd Pharmaceutical compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264989A1 (en) * 1986-10-01 1988-04-27 PROTER S.p.A. Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
EP0364944A1 (en) * 1988-10-17 1990-04-25 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
EP0519428A2 (en) * 1991-06-21 1992-12-23 Takeda Chemical Industries, Ltd. Cyclodextrin composition
EP0598337A2 (en) * 1992-11-13 1994-05-25 VECTORPHARMA INTERNATIONAL S.p.A. Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent

Also Published As

Publication number Publication date
BR9706537A (pt) 1999-12-28
EP0862423A1 (fr) 1998-09-09
ATE275945T1 (de) 2004-10-15
IL123336A (en) 2001-03-19
JPH11512115A (ja) 1999-10-19
PL189358B1 (pl) 2005-07-29
EP0862423B1 (fr) 2004-09-15
KR980009519A (ko) 1998-04-30
IL123336A0 (en) 1998-09-24
MX9801727A (es) 1998-11-30
CA2231342C (fr) 2008-04-08
CN1197388A (zh) 1998-10-28
ES2230608T3 (es) 2005-05-01
WO1998001118A1 (fr) 1998-01-15
US5952383A (en) 1999-09-14
CN1196477C (zh) 2005-04-13
JP4209467B2 (ja) 2009-01-14
CA2231342A1 (fr) 1998-01-15
AU3263197A (en) 1998-02-02
DE69730688T2 (de) 2005-09-22
PL325282A1 (en) 1998-07-20
DE69730688D1 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
NL1003503C2 (nl) Farmaceutische samenstelling voor orale toediening.
CN100363055C (zh) 用作c型肝炎病毒蛋白酶抑制剂的药物组合物
US20060211688A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
KR20190084035A (ko) 칸나비노이드의 희석 제형 및 이의 제조 방법
US20060241175A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
JPWO2004048497A1 (ja) 高度不飽和脂肪酸、その塩、またはそのエステルを含有する外用組成物
JP2002513750A (ja) 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム
JP2001525363A (ja) オメガ−３脂肪酸油を含む医薬組成物
MX2007001558A (es) Formulaciones novedosas de fenofibrato y metodos de tratamiento relacionados.
KR20010008804A (ko) 카르두스 마리아누스 추출물 또는 이로부터 정제된 실리빈을함유하는 경구용 마이크로에멀젼 조성물
JP2011116781A (ja) 脳梗塞の予防及び治療用医薬品の製造におけるｌ−ブチルフタリドの使用
US5958876A (en) Cyclosporin-containing pharmaceutical compositions
KR100304326B1 (ko) 사이클로스포린-함유마이크로에멀젼예비농축액조성물
EP0869810B1 (en) Cyclosporin-containing soft capsule preparations
WO1998011881A1 (fr) Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
KR100300251B1 (ko) 사이클로스포린함유약학적조성물
JP6908449B2 (ja) 医薬組成物
AU741923B2 (en) Pharmaceutical compositions
CN110709105A (zh) 载有药物的非水系组合物及其制备方法
JPH0390022A (ja) 皮膚疾患治療用外用剤
KR100455216B1 (ko) 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
AU753018B2 (en) Cyclosporin-containing soft capsule preparations
AU722285B2 (en) Cyclosporin-containing soft capsule preparations
WO2005016322A2 (en) Pharmaceutical compositions of lavendustin
KR19990066706A (ko) 사이클로스포린-함유 마이크로에멀젼 예비농축액 조성물

Legal Events

Date Code Title Description
AD1B A search report has been drawn up
PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20100201